Cite
HARVARD Citation
Croft, N. et al. (2021). Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study. Lancet gastroenterology and hepatology. pp. 616-627. [Online].